United States molecular diagnostics market is anticipated to cross US$ 9 billion by the end of year 2024
For More Info: http://www.renub.com/united-states-us-molecular-diagnostics-market-to-be-more-than-usd-9-billion-by-2024-52-nd.php In the United States, Cancer is a leading cause of death that can be detected early because of molecular diagnostic tests. This is why the molecular diagnostics is the primary growth driver for this market. United States molecular diagnostics market is anticipated to cross US$ 9 billion by the end of year 2024. Utilization of molecular diagnostics which help to reduce healthcare costs for patients by avoiding unnecessary drugs, medical care, and chemotherapy. It is also useful to detect cancer biomarkers to improve the survival rate of patients. The capability of molecular diagnostics to authenticate cancer biomarkers and improve patient care will lead to the growth of this market during the projected period. Access Full Research: http://www.renub.com/united-states-usa-molecular-diagnostics-market-test-volume-forecast-and-companies-35-p.php Presently, in the field of medical diagnostics, molecular diagnostics for cancer test offers one of the key areas for innovation and expansion. Molecular oncology tests have emerged as a substantial market segment. The United States leads the regional market for blood screening and blood products. Molecular diagnostics is also a significant tool for Food Pathogen Detection Testing and HLA Testing as well as other diseases. Characterization & Application of the United State Molecular Diagnostics Market The United States molecular diagnostics market based on application; the market is broadly characterized into Oncology Test, Infectious diseases, Genetic tests. The Oncology molecular diagnostics market is determined by technological advancements, growing prevalence of cancer, and rising focus on personalized medicine.
★
★
★
★
★
120 views • 10 slides
